http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-114767686-A
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4fb38ebd40c70e97cc5f1519c6699162 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-519 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-519 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-20 |
filingDate | 2022-04-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1f1eb084856aec7cbb8defe5a917fa7d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e16ef679ec6a34e8d7cd96ceed0f9e05 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6a560f5f4ef094f20265280b57e4f190 |
publicationDate | 2022-07-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-114767686-A |
titleOfInvention | Application of PF-04691502 in the preparation of medicaments for preventing and/or treating adenovirus infection |
abstract | The invention belongs to the technical field of medicine, and more particularly relates to the application of PF-04691502 in the preparation of medicines for preventing and/or treating adenovirus infection. Disclosed is the application of PF-04691502 in the preparation of a drug for inhibiting adenovirus and/or a drug for preventing and/or treating adenovirus infection, thereby providing a safe and effective small molecule compound for clinical adenovirus treatment. PF‑04691502 can effectively inhibit the replication of adenovirus within the non-toxic range, and can be further developed as a drug for the treatment or prevention of diseases caused by adenovirus infection, and has broad application prospects. |
priorityDate | 2022-04-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 102.